Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor

Chemico-Biological Interactions

Volumn 206, Issue 2, 2013, Pages 153-165

  Saraswati, Sarita ^a   Agrawal, S S ^b   Alhaider, Abdulqader A ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b AMITY UNIVERSITY   (India)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Caspase 3; CD31; Ehrlich ascites carcinoma; Ursolic acid; VEGF

Indexed keywords

CASPASE 3; CATALASE; CD31 ANTIGEN; CYCLOPHOSPHAMIDE; GLUTATHIONE; HEMOGLOBIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; PROTEIN BAX; PROTEIN BCL 2; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; URSOLIC ACID; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; EHRLICH ASCITES TUMOR; ERYTHROCYTE COUNT; FEMALE; HEMATOCRIT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LEUKOCYTE COUNT; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; TUMOR VOLUME; UPREGULATION;

CASPASE-3; CD31; EHRLICH ASCITES CARCINOMA; URSOLIC ACID; VEGF;

ANIMALS; ANTIGENS, CD31; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BODY WEIGHT; CARCINOMA, EHRLICH TUMOR; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CYTOKINES; DOWN-REGULATION; KAPLAN-MEIER ESTIMATE; MICE; MITOCHONDRIA; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; TRANSPLANTATION, HOMOLOGOUS; TRITERPENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 84885337258     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2013.09.004     Document Type: Article

References (73)

1. J. Folkman, and Y. Shing Angiogenesis J. Biol. Chem. 267 1992 10931 10934
2. P. Carmeliet Angiogenesis in health and disease Nat. Med. 9 2003 653 660 (Pubitemid 36749213)
3. G.D. Yancopoulos, S. Davis, N.W. Gale, J.S. Rudge, S. Wiegand, and J. Holash Vascular-specific growth factors and blood vessel formation Nature 407 2000 242 248
4. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
5. N. Ferrara, and T. Davis-Smyth The biology of vascular endothelial growth factor Endocr. Rev. 18 1997 4 25 (Pubitemid 27076453)
6. B. Hoeben, M.S. Landuyt, H. Highley, A.T. van Wildiers, and E.A.D. Oosterom Bruijin, vascular endothelial growth factor and angiogenesis Pharmacol. Rev. 6 2004 549 580
7. N. Ferrara Vascular endothelial growth factor: basic science and clinical progress Endocr. Rev. 25 2004 581 611 (Pubitemid 39099316)
8. D.W. Leung, G. Cachianes, W.J. Kuang, D.V. Goeddel, and N. Ferrara Vascular endothelial growth factor is a secreted angiogenic mitogen Science 246 1989 1306 1309 (Pubitemid 20066716)
9. S. Soker, H. Fidder, G. Neufeld, and M. Klagsbrun Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain J. Biol. Chem. 271 1996 5761 5767
10. K.J. Kim, B. Li, J. Winer, M. Armanini, N. Gillett, H.S. Phillips, and N. Ferrara Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo Nature 362 1993 841 844 (Pubitemid 23132159)
11. B. Millauer, M.P. Longhi, K.H. Plate, L.K. Shawver, W. Risau, A. Ullrich, and L.M. Strawn Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo Cancer Res. 56 1996 1615 1620 (Pubitemid 26104026)
12. C. de Vries, J.A. Escobedo, H. Ueno, K. Houck, N. Ferrara, and L.T. Williams The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor Science 255 1992 989 991
13. J. Folkman, and M. Klagsbrun Angiogenic factors Science 235 1987 442 447 (Pubitemid 17009577)
14. N. Akhtar, M.L. Padilla, E.B. Dickerson, H. Steinberg, M. Breen, R. Auerbach, and S.C. Helfand Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model Neoplasia 6 2004 106 116 (Pubitemid 38544598)
15. G. Trinchieri Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity Annu. Rev. Immunol. 131 1995 251 276
16. T.A. Fong, L.K. Shawver, L. Sun, C. Tang, H. App, T.J. Powell, Y.H. Kim, R. Schreck, X. Wang, W. Risau, A. Ullrich, K.P. Hirth, and G. McMahon SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types Cancer Res. 59 1999 99 106 (Pubitemid 29062964)
17. M. Woo, M. Hakem, and T.W. Mak Executionary pathway for apoptosis: lessons from mutant mice Cell Res. 10 2000 267 278
18. J.C. Reed Mechanisms of apoptosis Am. J. Pathol. 157 2000 1415 1430
19. E.K. Yim, M.J. Lee, K.H. Lee, S.J. Um, and J.S. Park Antiproliferative and antiviral mechanisms of ursolic acid and dexamethasone in cervical carcinoma cell lines Int. J. Gynecol. Cancer 16 2006 2023 2031
20. E. Kassi, Z. Papoutsi, H. Pratsinis, N. Aligiannis, M. Manoussakis, and P. Moutsatsou Ursolic acid, a naturally occurring triterpenoid, demonstrates anticancer activity on human prostate cancer cells J. Cancer Res. Clin. Oncol. 133 2007 493 500 (Pubitemid 46800670)
21. E. Kassi, T.G. Sourlingas, M. Spiliotaki, Z. Papoutsi, H. Pratsinis, N. Aligiannis, and P. Moutsatsou Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells Cancer Invest. 27 2009 723 733
22. C. Tang, Y.H. Lu, J.H. Xie, F. Wang, J.N. Zou, J.S. Yang, Y.Y. Xing, and T. Xi Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis Anticancer Drugs 20 2009 249 258
23. Y. Zhang, C. Kong, Y. Zeng, L. Wang, Z. Li, H. Wang, C. Xu, and Y. Sun Ursolic acid induces PC-3 cell apoptosis via activation of JNK and inhibition of Akt pathways in vitro Mol. Carcinog. 49 2010 374 385
24. Y. Limami, A. Pinon, D.Y. Leger, Y. Mousseau, J. Cook-Moreau, J.L. Beneytout, C. Delage, B. Liagre, and A. Simon HT-29 colorectal cancer cells undergoing apoptosis overexpress COX-2 to delay ursolic acid-induced cell death Biochime 93 2011 749 757
25. M.T. Huang, C.T. Ho, Z.Y. Wang, T. Ferraro, Y.R. Lou, K. Stauber, W. Ma, C. Georgiadis, J.D. Laskin, and A.H. Conney Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid Cancer Res. 54 1994 701 708 (Pubitemid 24068325)
26. M.S. Kiran, R.I. Viji, V.B. Sameer Kumar, and P.R. Sudhakaran Modulation of angiogenic factors by ursolic acid Biochem. Biophys. Res. Commun. 371 2008 556 560
27. R. Gayathri, D.K. Priya, G.R. Gunassekaran, and D. Sakthisekaran Ursolic acid attenuates oxidative stress-mediated hepatocellular carcinoma induction by diethylnitrosamine in male Wistar rats Asian Pac. J. Cancer Prev. 10 2009 933 938
28. X. Wang, L. Li, B. Wang, and J. Xiang Effects of ursolic acid on the proliferation and apoptosis of human ovarian J. Huazhong Univ. Sci. Technol. Med. Sci. 29 2009 761 764
29. Y.X. Yu, Z.L. Gu, J.L. Yin, W.H. Chou, C.Y. Kwok, Z.H. Qin, and Z.Q. Liang Ursolic acid induces human hepatoma cell line SMMC-7721 apoptosis via p53-dependent pathway Chin. Med. J. 123 2010 1915 1923
30. R.E. De Angel, S.M. Smith, R.D. Glickman, S.N. Perkins, and S.D. Hursting Anti-tumor effects of ursolic acid in a mouse model of postmenopausal breast cancer Nutr. Cancer 62 2010 1074 1086
31. S.S. Agrawal, S. Saraswati, R. Mathur, and M. Pandey Antitumor properties of boswellic acid against Ehrlich ascites cells bearing mouse Food Chem. Toxicol. 49 2011 1924 1934
32. S.S. Agrawal, S. Saraswati, R. Mathur, and M. Pandey Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line Life Sci. 89 2011 147 158
33. S. Saraswati, and S.S. Agrawal Brucine, an indole alkaloid from Strychnos nux-vomica attenuates VEGF-induced angiogenesis via inhibiting VEGFR2 signaling pathway in vitro and in vivo Cancer Lett. 332 2013 83 93
34. S. Saraswati, P.K. Kanuajia, S. Kumar, R. Kumar, and A.A. Alhaider Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis Mol. Cancer 12 2013 82
35. 2 consumption, and tumor interstitial fluid pressure Anticancer Res. 21 2001 2827 2833 (Pubitemid 33054463)
36. D. Giustarini, R. Rossi, A. Milzani, and I. Dalle-Donne Nitrite and nitrate measurement by Griess reagent in human plasma: evaluation of interferences and standardization Methods Enzymol. 440 2008 361 380
37. M.M. Bradford A dye binding assay for protein Anal. Biochem. 72 1976 248 254
38. M.S. O'Reilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios, W.S. Lane, E. Flynn, J.R. Birkhead, B.R. Olsen, and J. Folkman Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 1997 277 285 (Pubitemid 28015876)
39. P. Sur, and D.K. Ganguly Tea plant roots extract (TRE) as an antineoplastic agent Planta Med. 60 1994 106 109 (Pubitemid 24120889)
40. H. Yoshiji, S. Kuriyama, M. Kawata, J. Yoshii, Y. Ikenaka, R. Noguchi, T. Nakatani, H. Tsujinoue, and H. Fukui The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor Clin. Cancer Res. 7 2001 1073 1078 (Pubitemid 32708747)
41. H. Yoshiji, S. Kuriyama, D.K. Ways, J. Yoshii, Y. Miyamoto, M. Kawata, Y. Ikenaka, H. Tsujinoue, T. Nakatani, M. Shibuya, and H. Fukui Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis Cancer Res. 59 1999 4413 4418 (Pubitemid 29418762)
42. L. Hlkatky, P. Hahnfeldt, and J. Folkman Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us J. Natl. Cancer Inst. 94 2002 883 893 (Pubitemid 34778087)
43. H. Lettre Tests of compounds against the Ehrlich mouse ascites tumor Cancer Res. 2 1955 125 128
44. K. Sugiura Effect of various compounds on the Ehrlich ascites carcinoma Cancer Res. 13 1953 431 441
45. A. Brkovic, and M.G. Sirois Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis J. Cell. Biochem. 100 2007 727 737 (Pubitemid 46187709)
46. B.P. Salimath, A. Tabassum, E.G. Anupama, Bindumalini, G.B. Preethi, and P.V. Salimath Molecular mechanism of action of butyric acid in Ehrlich ascites tumor cells Nutr. Res. 19 1999 589 600 (Pubitemid 29205541)
47. J. Liu Pharmacology of oleanolic and ursolic acid J. Ethnopharmacol. 49 1995 57 68
48. D. Es-saady, A. Simon, M. Ollier, J.C. Maurizis, A.J. Chulia, and C. Delage Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrest Cancer Lett. 10 1996 193 197 (Pubitemid 126745145)
49. J. Li, W.J. Guo, and Q.Y. Yang Effects of ursolic acid and oleanolic acid on human colon carcinoma cell line HCT15 World J. Gastroenterol. 8 2002 93 495
50. D.O. Kennedy, A. Kojima, T. Hasuma, Y. Yano, S. Otani, and Y.I. Matsui Growth inhibitory effect of green tea extract and (-)-epigallocatechin in Ehrlich ascites tumor cells involves a cellular thiol-dependent activation of mitogenic-activated protein kinases Chem. Biol. 134 2001 113 133 (Pubitemid 32304506)
51. J. Folkman Angiogenesis: an organizing principle for drug discovery Nat. Rev. Drug Discov. 6 2007 273 286 (Pubitemid 46505878)
52. J.C. Luo, S. Yamaguchi, A. Shinkai, K. Shitara, and M. Shibuya Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors Cancer Res. 58 1998 2652 2660 (Pubitemid 28275440)
53. H. Sadick, R. Naim, U. Gossler, K. Hormann, and F. Riedel Angiogenesis in hereditary hemorrhagic telangiectasia: VEGF165 plasma concentration in correlation to the VEGF expression and microvessel density Int. J. Mol. Med. 15 2005 15 19
54. S. Mesiano, N. Ferrara, and R.B. Jaffe Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization Am. J. Pathol. 153 1998 1249 1256 (Pubitemid 28465848)
55. K.J. Kim, B. Li, J. Winer, M. Armanini, N. Gillet, H.S. Phillips, and N. Ferrara Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo Nature 362 1993 841 842
56. M.P. Colombo, and G. Trinchieri Interleukin-12 in anti-tumor immunity and immunotherapy Cytokine Growth Factor Rev. 13 2002 155 168 (Pubitemid 34229390)
57. T. Syrovets, M. Jendrach, A. Rohwedder, A. Schüle, and T. Simmet Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKKbeta-mediated NF-kappaB activation Blood 97 2001 3941 3950
58. B.D. Clarkson, and J.H. Burchenal Preliminary screening of antineoplastic drugs Prog. Clin. Cancer 1 1965 625 629
59. C. Oberling, and M. Guerin The role of viruses in the production of cancer Adv. Cancer Res. 2 1954 323 353
60. M. Maseki, I. Nishiagaki, M. Hagishara, Y. Tamoda, and K. Yagi Lipid peroxidation levels and lipid content of serum lipoprotein fractions of pregnant subjects with or without pre-eclampsia Clin. Chim. Acta 41 1981 424 426
61. V.E. Price, and R.E. Greenfield Anemia in cancer J.P. Greenstein, A. Haddow, Advances in Cancer Research 1950 Academic Press New York 199 200
62. L.D. Fenninger, and G.B. Mider J.P. Greenstein, A. Haddow, Advances in Cancer Research 1954 Academic Press New York
63. S.M. Choudhury, G. Roy, M. Gupta, and U.K. Majumder The central nervous system depressant activities of Mycotoxin MT81 and its acetylated and benzoylated analogues Al Ameen J. Med. Sci. 1 2008 104 114
64. P.A. Cerutti Oxy-radicals and cancer Lancet 344 1994 862 863 (Pubitemid 24290388)
65. A. Meister Glutathione metabolism and its selective modification J. Biochem. 263 1988 17205 17208 (Pubitemid 19029311)
66. J.M. Mates, C. Perez-Gomez, and I. Nunez de Castro Antioxidant enzymes and human disease Clin. Biochem. 32 1999 595 603
67. A.J. Sinclair, A.H. Barnett, and J. Lunie Free radical and auto-oxidant systems in health and disease Br. J. Hosp. Med. 43 1990 334 344 (Pubitemid 20172729)
68. J. Hasan, R. Byers, and G.C. Jayson Intra-tumoral microvessel density in human solid tumors Br. J. Cancer 86 2002 1566 1577 (Pubitemid 34628110)
69. T.M. Miller, K.L. Moulder, C.M. Knudson, D.J. Creedon, M. Deshmukh, S.J. Korsmeyer, and E.M. Johnson Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death J. Cell Biol. 139 1997 205 217 (Pubitemid 27444092)
70. M. Missotten, P.A. Fernandez, R. Sadoul, and J.C. Martinou Bax and Bak proteins require caspase activity to trigger apoptosis in sympathetic neurons Neuroreport 9 1998 15 19 (Pubitemid 28046646)
71. N.A. Thornberry, and Y. Lazebnik Caspases: enemies within Science 281 1998 1312 1316 (Pubitemid 28406817)
72. S. Fulda, and K.M. Debatin Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy Oncogene 25 2006 4798 4811 (Pubitemid 44187627)
73. A. Debnath, A. Saha, S. Gomes, P. Biswas, B. Chakrabarti, A.K. Giri, S.D. Biswas, and A. Gupta Gomes, A lethal cardiotoxic-cytotoxic protein from the Indian monocellate cobra (Naja kaouthia) venom Toxicon 56 2010 569 579